Abstract
The in vitro activity of LY 264826, a new glycopeptide antibiotic, was compared with that of vancomycin against 100 strains each of methicillin-resistant Staphylococcus aureus and Clostridium difficile. LY 264826 was more active, by weight, than vancomycin against the isolates tested. The human serum protein binding of LY 264826 was 15.3% (range, 9.8 to 21.8%).
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Peterson L. R., Gerding D. N., Fasching C. E., Costas-Martinez C. Assay of 27 antimicrobials using a microbiological method. Minn Med. 1983 May;66(5):321–324. [PubMed] [Google Scholar]
- Peterson L. R., Hall W. H., Zinneman H. H., Gerding D. N. Standardization of a preparative ultracentrifuge method for quantitative determination or protein binding of seven antibiotics. J Infect Dis. 1977 Dec;136(6):778–783. doi: 10.1093/infdis/136.6.778. [DOI] [PubMed] [Google Scholar]